Prediction of solubility on recombinant expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli
暂无分享,去创建一个
Mats Wahlgren | M. Wahlgren | Qijun Chen | Qijun Chen | Sanjay Ahuja | Satpal Ahuja | S. Ahuja | S. Ahuja
[1] M. Wahlgren,et al. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells and secretion of cytokines (IL-1-beta, IL-1RA, IL-6, IL-8, IL-10, TGF beta, TNF alpha, G-CSF, GM-CSF. , 1995, Scandinavian journal of immunology.
[2] D. Davies,et al. Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[3] Pär Nordlund,et al. Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli , 2005, Nature Methods.
[4] J. Kane,et al. Properties of recombinant protein-containing inclusion bodies in Escherichia coli. , 1991, Bioprocess technology.
[5] A. Sahlén,et al. Identification of Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) as the Rosetting Ligand of the Malaria Parasite P. falciparum , 1998, The Journal of experimental medicine.
[6] G. Dale,et al. Improving protein solubility through rationally designed amino acid replacements: solubilization of the trimethoprim-resistant type S1 dihydrofolate reductase. , 1994, Protein engineering.
[7] Jürgen Pleiss,et al. How to find soluble proteins: a comprehensive analysis of alpha/beta hydrolases for recombinant expression in E. coli , 2005, BMC Genomics.
[8] H. P. Sørensen,et al. Advanced genetic strategies for recombinant protein expression in Escherichia coli. , 2005, Journal of biotechnology.
[9] A. Saul,et al. Biochemical and Immunological Characterization of Bacterially Expressed and Refolded Plasmodium falciparum 42-Kilodalton C-Terminal Merozoite Surface Protein 1 , 2003, Infection and Immunity.
[10] David E Hill,et al. High-throughput expression of C. elegans proteins. , 2004, Genome research.
[11] Fabrizio Chiti,et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[12] Qijun Chen,et al. Optimized expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli , 2004, Malaria Journal.
[13] David L. Wilkinson,et al. Predicting the Solubility of Recombinant Proteins in Escherichia coli , 1991, Bio/Technology.
[14] T. Terwilliger,et al. Engineering and characterization of a superfolder green fluorescent protein , 2006, Nature Biotechnology.
[15] Hong Zhou,et al. Posttranslational Modification of Recombinant Plasmodium falciparum Apical Membrane Antigen 1: Impact on Functional Immune Responses to a Malaria Vaccine Candidate , 2005, Infection and Immunity.
[16] Sanjay K. Singh,et al. Biochemical, Biophysical, and Functional Characterization of Bacterially Expressed and Refolded Receptor Binding Domain ofPlasmodium vivax Duffy-binding Protein* , 2001, The Journal of Biological Chemistry.
[17] Nirbhay Kumar,et al. Extra terminal residues have a profound effect on the folding and solubility of a Plasmodium falciparum sexual stage-specific protein over-expressed in Escherichia coli. , 2002, European journal of biochemistry.
[18] Kane Jf,et al. Properties of recombinant protein-containing inclusion bodies in Escherichia coli. , 1991 .
[19] B. Gamain,et al. Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. , 2000, Molecular and biochemical parasitology.
[20] Joseph D. Smith,et al. Functional interdependence of the DBLbeta domain and c2 region for binding of the Plasmodium falciparum variant antigen to ICAM-1. , 2004, Molecular and biochemical parasitology.
[21] J. Abrams,et al. Adhesion of Plasmodium Falciparwn‐lnfected Erythroeytes to Human Cells and Seeretion of Cytokines (IL‐1‐β, IL‐1RA, IL‐6, IL‐8, IL‐10, TGFβ, TNFα, G‐CSF, GM‐CSF) , 1995 .